From the Department of Orthopaedic Surgery, University of Chicago, Chicago, IL.
J Am Acad Orthop Surg. 2022 Feb 1;30(3):e384-e394. doi: 10.5435/JAAOS-D-21-00561.
The purpose of this meta-analysis was to determine whether perioperative fascia iliaca compartment blockade (FICB) decreases mortality in patients with hip fracture.
MEDLINE (PubMed and Ovid platforms), Web of Science, EMBASE, and Cochrane Database of Systemic Reviews were screened for "fascia iliaca compartment block, hip fracture" articles in English, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, from January 1, 2005, to March 1, 2020. All relevant randomized controlled trials and cohort and case-control studies were included for analysis. Relevant article titles were identified, and their corresponding abstracts were independently reviewed by two authors for inclusion. The full-text articles were then obtained for all relevant identified abstracts and assessed for inclusion in the meta-analysis. Conflicts in quality assessment between the two independent reviewers were resolved by a consensus vote of all authors.
Study quality was assessed objectively using the Jadad and Newcastle-Ottawa Scale. This meta-analysis was done in accordance with the PRISMA (http://links.lww.com/JAAOS/A731) and QUORUM guidelines. Quantitative synthesis analysis was done using Cochrane Reviews Review Manager (version 5.3). All analyses were completed using random-effects models and comparing the individual effect sizes within each study.
Management of hip fracture pain with FICB does not markedly decrease short-term mortality. Our findings support the continued use of FICB for the management of hip fractures in geriatric patients and suggest the need for future prospective randomized controlled trials to further determine FICB's effect on short-term and long-term mortality and functional status.
Therapeutic level I.
本荟萃分析旨在确定髋关节骨折患者围手术期股外侧肌间隙阻滞(FICB)是否降低死亡率。
根据系统评价和荟萃分析的首选报告项目(PRISMA)(http://links.lww.com/JAAOS/A731)和 QUORUM 指南,我们在英语中以“筋膜间室阻滞,髋关节骨折”为关键词,在 MEDLINE(PubMed 和 Ovid 平台)、Web of Science、EMBASE 和 Cochrane 系统评价数据库中对 2005 年 1 月 1 日至 2020 年 3 月 1 日的相关文献进行了筛选。所有相关的随机对照试验以及队列和病例对照研究均纳入分析。确定了相关文章的标题,并由两位作者独立审查其摘要以确定是否纳入。然后,获取所有相关已识别摘要的全文文章,并评估是否纳入荟萃分析。如果两位独立评审员在质量评估方面存在分歧,则由所有作者投票解决。
使用 Jadad 和 Newcastle-Ottawa 量表客观评估研究质量。本荟萃分析符合 PRISMA(http://links.lww.com/JAAOS/A731)和 QUORUM 指南。使用 Cochrane Reviews Review Manager(版本 5.3)进行定量综合分析。所有分析均使用随机效应模型完成,并在每个研究中比较个体效应大小。
使用 FICB 治疗髋关节骨折疼痛并不会明显降低短期死亡率。我们的研究结果支持继续使用 FICB 治疗老年患者的髋关节骨折,并表明需要进行未来的前瞻性随机对照试验,以进一步确定 FICB 对短期和长期死亡率和功能状态的影响。
治疗学 1 级。